The nation’s top pharmacy benefit manager (PBM) lobbying group is going on the offensive, stepping up its advocacy efforts against the pharmaceutical industry after Congress passed a PBM industry overhaul last winter. The pharmaceutical industry spent years pointing fingers at pharmacy benefit managers as the reason for high drug costs, and Congress finally was able…
